StockOtters
StockOttersSupply Chain Map
SK Biopharmaceuticals Co., Ltd. logo

SK Biopharmaceuticals Co., Ltd.

326030.KS

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
411
Cost of Revenue
32
Gross Profit
378
Gross Margin
92.1%
Operating Income
72
Operating Margin
17.6%
Net Income
181
Net Margin
44.0%
EPS (Basic)
$2.00
EPS (Diluted)
$2.00
EBITDA
76
EBITDA Margin
18.4%

2023

12/31/2023

Revenue
266
Cost of Revenue
35
Gross Profit
231
Gross Margin
86.9%
Operating Income
-28
Operating Margin
-10.6%
Net Income
-25
Net Margin
-9.3%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-15
EBITDA Margin
-5.7%

2022

12/31/2022

Revenue
185
Cost of Revenue
28
Gross Profit
156
Gross Margin
84.7%
Operating Income
-98
Operating Margin
-53.2%
Net Income
-105
Net Margin
-56.6%
EPS (Basic)
$-1.00
EPS (Diluted)
$-1.00
EBITDA
-94
EBITDA Margin
-51.1%

2021

12/31/2021

Revenue
314
Cost of Revenue
17
Gross Profit
297
Gross Margin
94.7%
Operating Income
56
Operating Margin
17.7%
Net Income
49
Net Margin
15.5%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
80
EBITDA Margin
25.5%

2020

12/31/2020

Revenue
19
Cost of Revenue
1
Gross Profit
18
Gross Margin
92.4%
Operating Income
-180
Operating Margin
-921.2%
Net Income
-186
Net Margin
-951.6%
EPS (Basic)
$-3.00
EPS (Diluted)
$-3.00
EBITDA
-168
EBITDA Margin
-863.8%